Sentinus LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3M Buy
12,276
+1,039
+9% +$242K 0.27% 91
2025
Q4
$2.33M Buy
11,237
+5,130
+84% +$1.01M 0.22% 93
2025
Q3
$1.13M Buy
6,107
+168
+3% +$28.8K 0.25% 72
2025
Q2
$907K Buy
5,939
+406
+7% +$62.4K 0.22% 74
2025
Q1
$918K Buy
5,533
+610
+12% +$95.4K 0.26% 67
2024
Q4
$712K Sell
4,923
-657
-12% -$102K 0.21% 81
2024
Q3
$904K Buy
5,580
+21
+0.4% +$3.35K 0.27% 65
2024
Q2
$813K Buy
5,559
+476
+9% +$70.8K 0.26% 68
2024
Q1
$804K Buy
+5,083
New +$809K 0.28% 64
2023
Q2
$883K Buy
5,337
+498
+10% +$80.4K 0.28% 65
2023
Q1
$750K Buy
4,839
+3,195
+194% +$516K 0.25% 72
2022
Q4
$294K Buy
1,644
+1
+0.1% +$173 0.17% 85
2022
Q3
$268K Buy
+1,643
New +$278K 0.17% 82

Other funds holding JNJ

Sentinus LLC's JNJ Position: Q1 2026 in Review

Sentinus LLC increased its Johnson & Johnson (JNJ) stake by 9.2% in Q1 2026, buying an estimated $242K and bringing the position to 12,276 shares worth $3M. The position accounts for 0.27% of the portfolio, ranked #91.

Sentinus LLC first reported a position in JNJ in Q3 2022 and has held it in 13 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sentinus LLC held 12,276 shares of Johnson & Johnson worth $3M as of Q1 2026.
  • Sentinus LLC bought 1,039 Johnson & Johnson shares in Q1 2026, an estimated $242K.
  • Johnson & Johnson made up 0.27% of Sentinus LLC's portfolio in Q1 2026, its #91 holding.
  • Sentinus LLC first reported a position in Johnson & Johnson in Q3 2022 and has held it in 13 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.